Recombinant Human TERT Protein，His

Telomerase reverse transcriptase (TERT) is a critical enzyme that plays a key role in the maintenance of telomeres, the protective structures at the ends of chromosomes. Telomeres shorten with each cell division, leading to cellular aging and ultimately to senescence or apoptosis. The reactivation of TERT is often observed in cancer cells, enabling them to proliferate indefinitely by maintaining telomere length. Research into TERT has gained significant attention due to its dual role in both aging and cancer. Understanding the mechanisms that regulate TERT expression and activity can provide insights into potential therapeutic targets for age-related diseases and cancer treatment. Studies have shown that various factors, including genetic mutations, epigenetic modifications, and signaling pathways, can influence TERT expression. Developing recombinant TERT proteins has opened new avenues for investigating its functional roles in telomere biology and elucidating its involvement in tumorigenesis. By exploring TERT's molecular interactions and biochemical properties, researchers aim to design targeted interventions that can modulate its activity in a clinical context. Additionally, TERT is being studied as a biomarker for cancer diagnosis and prognosis, further underscoring its significance in both basic and applied biological research.